Literature DB >> 32618259

Early Postnatal and Preschool-Age Infection by Fasciola spp.: Report of Five Cases from Vietnam and Worldwide Review.

Nguyen Van De1, Thanh Hoa Le2, Veronica H Agramunt3, Santiago Mas-Coma3.   

Abstract

Fascioliasis is reported in five Vietnamese children aged 4 years or younger. A 10-month-old girl child and a 12-month-old boy child are the youngest patients ever diagnosed. Eggs in stools suggested an infection occurred at 5-6 months and 7-8 months of age, respectively. DNA sequencing and egg size indicated this to be the first report of a verified Fasciola gigantica infection in so small children. No specific diagnosis could be obtained in two 3-year-old children detected in the acute phase. A big and gravid ectopic F. gigantica-like worm was surgically found in a 4-year-old boy presenting with peritonitis. A worldwide review showed only 38 past cases in preschool children. They included 3, 7, 12, and 16 cases of 1, 2, 3, and 4 years, respectively, with a faster infection increase in males from 2 years onward. Reports were from all continents, except Oceania, including severe complications and death. The causal agent, when specifically diagnosed, was always Fasciola hepatica. Analyses include detection in hospital, surveys, and family outbreaks; infection sources; disease phases; parasite burden; ectopic cases; symptom onset; eosinophilia; biochemical markers; and clinical complications. C-reactive protein, creatinine, and γ-glutamyl transferase are the most useful biomarkers. A serological test and a coprological analysis are recommended for so small children, in which typical symptoms may be overlooked. Treatment problems were described with many drugs, except triclabendazole. Triclabendazole should be considered the drug of choice for such small children. The possibility of a very early infection by Fasciola spp. should be henceforth considered.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32618259      PMCID: PMC7543854          DOI: 10.4269/ajtmh.20-0139

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   3.707


  59 in total

1.  High endemicity of human fascioliasis between Lake Titicaca and La Paz valley, Bolivia.

Authors:  J G Esteban; A Flores; R Angles; S Mas-Coma
Journal:  Trans R Soc Trop Med Hyg       Date:  1999 Mar-Apr       Impact factor: 2.184

2.  Anaemia in advanced chronic fasciolosis.

Authors:  M A Valero; N Gironès; M A García-Bodelón; M V Periago; I Chico-Calero; M Khoubbane; M Fresno; S Mas-Coma
Journal:  Acta Trop       Date:  2008-09-03       Impact factor: 3.112

3.  Lymnaea schirazensis, an overlooked snail distorting fascioliasis data: genotype, phenotype, ecology, worldwide spread, susceptibility, applicability.

Authors:  María Dolores Bargues; Patricio Artigas; Messaoud Khoubbane; Rosmary Flores; Peter Glöer; Raúl Rojas-García; Keyhan Ashrafi; Gerhard Falkner; Santiago Mas-Coma
Journal:  PLoS One       Date:  2011-09-29       Impact factor: 3.240

4.  High risk of bacterobilia in advanced experimental chronic fasciolosis.

Authors:  M A Valero; M Navarro; M A Garcia-Bodelon; A Marcilla; M Morales; J L Hernandez; P Mengual; S Mas-Coma
Journal:  Acta Trop       Date:  2006-10-24       Impact factor: 3.112

5.  Fascioliasis imported to Norway.

Authors:  Mogens Jensenius; Trond Flaegstad; Tore Stenstad; Tor Gjølberg; Ljiljana Vlatkovic; Line Schjøth-Iversen; Dag Berild; Gerard Bordmann; Bjørn Myrvang
Journal:  Scand J Infect Dis       Date:  2005

6.  A case of ectopic intraabdominal fascioliasis presented with acute abdomen.

Authors:  Gönül Tanir; Ayşe Karaman; Sehra Birgül Tüfekçı; Duygu Erdoğan; Nilden Tuygun; Ayşegül Taylan Ozkan
Journal:  Turk J Gastroenterol       Date:  2011-06       Impact factor: 1.852

7.  Diagnosis of human fasciolosis in the Gilan province of Northern Iran: application of cathepsin L-ELISA.

Authors:  Mohammad B Rokni; Jafar Massoud; Sandra M O'Neill; Michael Parkinson; John P Dalton
Journal:  Diagn Microbiol Infect Dis       Date:  2002-10       Impact factor: 2.803

8.  [Emergence in humans of fascioliasis (from Fasciola gigantica) and intestinal distomatosis (from Fasciolopsis buski) in Laos].

Authors:  Thao Duong Quang; Thanh Hai Duong; Dominique Richard-Lenoble; Peter Odermatt; Keomanivanh Khammanivong
Journal:  Sante       Date:  2008 Jul-Sep

Review 9.  Climate change effects on trematodiases, with emphasis on zoonotic fascioliasis and schistosomiasis.

Authors:  Santiago Mas-Coma; Maria Adela Valero; Maria Dolores Bargues
Journal:  Vet Parasitol       Date:  2009-03-26       Impact factor: 2.738

10.  Field evaluation of a coproantigen detection test for fascioliasis diagnosis and surveillance in human hyperendemic areas of Andean countries.

Authors:  María Adela Valero; María Victoria Periago; Ignacio Pérez-Crespo; René Angles; Fidel Villegas; Carlos Aguirre; Wilma Strauss; José R Espinoza; Patricia Herrera; Angelica Terashima; Hugo Tamayo; Dirk Engels; Albis Francesco Gabrielli; Santiago Mas-Coma
Journal:  PLoS Negl Trop Dis       Date:  2012-09-13
View more
  3 in total

Review 1.  Human Fascioliasis: Current Epidemiological Status and Strategies for Diagnosis, Treatment, and Control.

Authors:  Maria Alejandra Caravedo; Miguel Mauricio Cabada
Journal:  Res Rep Trop Med       Date:  2020-11-26

2.  One Health Action against Human Fascioliasis in the Bolivian Altiplano: Food, Water, Housing, Behavioural Traditions, Social Aspects, and Livestock Management Linked to Disease Transmission and Infection Sources.

Authors:  René Angles; Paola Buchon; M Adela Valero; M Dolores Bargues; Santiago Mas-Coma
Journal:  Int J Environ Res Public Health       Date:  2022-01-20       Impact factor: 3.390

3.  Sheep and Cattle Reservoirs in the Highest Human Fascioliasis Hyperendemic Area: Experimental Transmission Capacity, Field Epidemiology, and Control Within a One Health Initiative in Bolivia.

Authors:  Santiago Mas-Coma; Paola Buchon; Ilra R Funatsu; Rene Angles; Patricio Artigas; M Adela Valero; M Dolores Bargues
Journal:  Front Vet Sci       Date:  2020-10-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.